MPG.eBooks - Description: CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.)

Read Now

The CADTH Canadian Drug Expert Committee (CDEC) recommends that ozenoxacin not be reimbursed for the treatment of impetigo

Bibliographic Details
Corporate Authors:	CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, October 2018
Edition:	Version: Final
Series:	CADTH common drug review
Subjects:	Insurance, Health, Reimbursement Quinolones / Therapeutic Use Child Canada Impetigo / Drug Therapy Infant Cost-benefit Analysis Aminopyridines / Therapeutic Use Treatment Outcome
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK539227
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The CADTH Canadian Drug Expert Committee (CDEC) recommends that ozenoxacin not be reimbursed for the treatment of impetigo
Physical Description:	1 PDF file (7 pages)